Clonal evolution of chemotherapy-resistant urothelial carcinoma-Reference-Cited by-同舟云学术

Clonal evolution of chemotherapy-resistant urothelial carcinoma

Published:2016-10-17 Issue:12 Volume:48 Page:1490-1499
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Faltas Bishoy M,Prandi Davide,Tagawa Scott T,Molina Ana M,Nanus David M,Sternberg Cora,Rosenberg Jonathan,Mosquera Juan Miguel,Robinson Brian,Elemento Olivier,Sboner Andrea,Beltran Himisha,Demichelis Francesca^ORCID,Rubin Mark A^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng.3692.pdf

Reference74 articles.

1. Howlader, N. et al. SEER Cancer Statistics Review, 1975–2010 (National Cancer Institute, Bethesda, Maryland, USA, 2013).

2. von der Maase, H. et al. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. J. Clin. Oncol. 23, 4602–4608 (2005).

3. Clark, P.E. et al. Bladder cancer. J. Natl. Compr. Canc. Netw. 11, 446–475 (2013).

4. Sternberg, C.N. et al. Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European Organization for Research and Treatment of Cancer Protocol no. 30924. J. Clin. Oncol. 19, 2638–2646 (2001).

5. Sternberg, C.N. et al. Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours. Eur. J. Cancer 42, 50–54 (2006).

Cited by 224 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of nucleotide excision repair and translesion DNA synthesis proteins in muscle-infiltrating bladder carcinoma;BMC Cancer;2024-09-05

2. Relationship between clonal evolution and drug resistance in bladder cancer: A genomic research review;Pharmacological Research;2024-08

3. Advances, recognition, and interpretation of molecular heterogeneity among conventional and subtype histology of urothelial carcinoma (UC): a survey among urologic pathologists and comprehensive review of the literature;Histopathology;2024-07-29

4. NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer;Journal of Clinical Oncology;2024-07-10

5. Integrative Single Cell Atlas Revealed Intratumoral Heterogeneity Generation from an Adaptive Epigenetic Cell State in Human Bladder Urothelial Carcinoma;Advanced Science;2024-04-06